Biofil Chemicals and Pharmaceuticals Limited

NSE BIOFILCHEM.NS

Biofil Chemicals and Pharmaceuticals Limited Market Capitalization on January 14, 2025: USD 10.23 M

Biofil Chemicals and Pharmaceuticals Limited Market Capitalization is USD 10.23 M on January 14, 2025, a -9.86% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Biofil Chemicals and Pharmaceuticals Limited 52-week high Market Capitalization is USD 17.29 M on September 16, 2024, which is 69.04% above the current Market Capitalization.
Biofil Chemicals and Pharmaceuticals Limited 52-week low Market Capitalization is USD 10.23 M on January 14, 2025, which is 0.00% below the current Market Capitalization.
Biofil Chemicals and Pharmaceuticals Limited average Market Capitalization for the last 52 weeks is USD 12.92 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NSE: BIOFILCHEM.NS

Biofil Chemicals and Pharmaceuticals Limited

CEO	Mr. Ramesh S. Shah
IPO Date	July 27, 2017
Location	India
Headquarters	11/12, Sector "E"
Employees	26
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials Petrochemicals

Description

Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic dippers and caps. It also provides job work service for manufacturing of pharmaceuticals. The company was incorporated in 1985 and is based in Indore, India.

Key trends

Past 5 years